Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

"" Company Results for June 2022 Quarter 

Here are the latest quarterly results of the stocks in the . For more detailed updates, check the latest stock quotes.

Click on title to sort Jun 2021 Jun 2022 YoY %-Change   Get More Info
 Name
asc
Net Sales 
(Rs m) 
PAT 
(Rs m) 
Net Sales 
(Rs m) 
PAT 
(Rs m) 
Net Sales 
(%) 
PAT 
(%) 
P/E* 
(x) 
AUROBINDO PHARMA 57,020 7,790 62,359 5,244 9.4% -32.7% 15.3  More Info 
AUROBINDO PHARMA 57,020 7,790 62,359 5,244 9.4% -32.7% 15.3  More Info 
AUROBINDO PHARMA 57,020 7,790 62,359 5,244 9.4% -32.7% 15.3  More Info 
AUROBINDO PHARMA 57,020 7,790 62,359 5,244 9.4% -32.7% 15.3  More Info 
BIOCON 17,606 1,645 21,395 2,104 21.5% 27.9% 29.4  More Info 
BIOCON 17,606 1,645 21,395 2,104 21.5% 27.9% 29.4  More Info 
CIPLA 55,044 7,118 53,752 7,066 -2.3% -0.7% 15.2  More Info 
CIPLA 55,044 7,118 53,752 7,066 -2.3% -0.7% 15.2  More Info 
CIPLA 55,044 7,118 53,752 7,066 -2.3% -0.7% 15.2  More Info 
DIVIS LABORATORIES 19,606 5,571 22,550 7,020 15.0% 26.0% 53.8  More Info 
DIVIS LABORATORIES 19,606 5,571 22,550 7,020 15.0% 26.0% 53.8  More Info 
GLENMARK PHARMA 29,649 3,065 27,773 2,111 -6.3% -31.1% N.A.  More Info 
LUPIN 42,702 5,480 37,438 -868 -12.3% -115.8% 18.4  More Info 
LUPIN 42,702 5,480 37,438 -868 -12.3% -115.8% 18.4  More Info 
LUPIN 42,702 5,480 37,438 -868 -12.3% -115.8% 18.4  More Info 
PIRAMAL ENTERPRISES 29,087 3,685 21,613 80,062 -25.7% 2,072.9% N.A.  More Info 
SUN PHARMA 97,187 14,087 107,618 20,959 10.7% 48.8% 13.0  More Info 
SUN PHARMA 97,187 14,087 107,618 20,959 10.7% 48.8% 13.0  More Info 
ZYDUS LIFESCIENCES 40,018 6,455 39,643 5,626 -0.9% -12.8% 11.4  More Info 
ZYDUS LIFESCIENCES 40,018 6,455 39,643 5,626 -0.9% -12.8% 11.4  More Info 
Sector Aggregate 928,887 131,218 954,805 193,156 2.8% 47.2%  

* Trailing 12 months earnings, excluding extraordinary / exceptional items.

Mar 2022 Results  |  Sep 2022 Results  |  Latest Quarter Results  |  View All Results